CHRISTIE BALLANTYNE to Pyrrolidines
This is a "connection" page, showing publications CHRISTIE BALLANTYNE has written about Pyrrolidines.
Connection Strength
0.197
-
Phase 2b Randomized Trial of the Oral PCSK9 Inhibitor MK-0616. J Am Coll Cardiol. 2023 04 25; 81(16):1553-1564.
Score: 0.197
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.